Jasper Therapeutics Inc.

NASDAQ: JSPR · Real-Time Price · USD
3.07
0.04 (1.32%)
At close: Aug 15, 2025, 3:59 PM
3.05
-0.65%
After-hours: Aug 15, 2025, 06:15 PM EDT

Jasper Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
71.64M 86.89M 38.25M 84.7M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
417K 417K 417K 345K
Other Long-Term Assets
820K 1.34M 1.18M 990K
Receivables
n/a 250K 1.16M 698K
Inventory
n/a n/a n/a n/a
Other Current Assets
646K 309K 714K 48K
Total Current Assets
75.81M 88.94M 41.73M 87.83M
Property-Plant & Equipment
2.85M 4.19M 5.45M 4.83M
Goodwill & Intangibles
n/a n/a -980K -668K
Total Long-Term Assets
4.09M 5.95M 6.63M 5.82M
Total Assets
79.9M 94.89M 48.36M 93.65M
Account Payables
4.03M 4.15M 1.77M 3.92M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 865K 505K
Other Current Liabilities
3.7M 5.49M 1.98M 280K
Total Current Liabilities
15.24M 12.37M 7.07M 8.02M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
2.26M 2.26M 2.52M 13.74M
Total Long-Term Liabilities
2.99M 4.08M 5.31M 16.12M
Total Liabilities
18.23M 16.45M 12.37M 24.14M
Total Debt
1.81M 2.79M 3.65M 2.88M
Common Stock
2K 1K 4K 4K
Retained Earnings
-240.87M -169.6M -105.14M -67.45M
Comprehensive Income
n/a n/a n/a -93.65M
Shareholders Equity
61.67M 78.44M 35.99M 69.52M
Total Investments
417K 417K 417K 345K